当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析

京新药业

(002020)

  

流通市值:138.71亿  总市值:164.97亿
流通股本:7.24亿   总股本:8.61亿

京新药业(002020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.81亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益568551.96万元,未分配利润318813.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产797864.86万元,负债229312.90万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,048,192,079.462,016,542,750.22956,068,676.244,158,550,673.09
营业总成本2,417,770,049.291,599,932,166.01785,814,459.843,369,944,245.48
其他经营收益
营业利润664,258,601.66450,138,341.44193,194,174.6843,605,995.2
利润总额664,916,102.75450,261,320.86193,215,939.31843,979,875.65
净利润581,417,539.53392,203,288.29165,381,300.92719,126,111.66
每股收益
其他综合收益-121,128.61-336,679.07-93,589.79709,602.25
综合收益总额581,296,410.92391,866,609.22165,287,711.13719,835,713.91
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,142,880,026.722,810,717,832.032,719,920,055.312,904,776,219.94
非流动资产:
非流动资产合计4,835,768,603.385,101,197,229.645,266,649,360.945,574,536,998.66
资产总计7,978,648,630.17,911,915,061.677,986,569,416.258,479,313,218.6
流动负债:
流动负债合计1,939,835,860.752,060,726,893.661,910,928,463.822,134,519,745.35
非流动负债:
非流动负债合计353,293,153.53355,040,836.29351,989,648.39343,249,680.34
负债合计2,293,129,014.282,415,767,729.952,262,918,112.212,477,769,425.69
所有者权益(或股东权益):
归属于母公司股东权益合计5,651,372,562.725,463,484,498.345,689,530,119.195,969,508,653.97
股东权益合计5,685,519,615.825,496,147,331.725,723,651,304.046,001,543,792.91
负债和股东权益合计7,978,648,630.17,911,915,061.677,986,569,416.258,479,313,218.6
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,990,689,343.981,949,788,386.33958,581,127.834,018,352,855.9
经营活动现金流出小计2,375,205,530.611,556,879,962.08795,688,384.133,292,191,485.09
经营活动产生的现金流量净额615,483,813.37392,908,424.25162,892,743.7726,161,370.81
投资活动产生的现金流量:
投资活动现金流入小计2,038,840,858.841,594,511,975.961,097,601,857.614,168,216,721.75
投资活动现金流出小计1,524,375,046.19961,922,973.01627,128,113.975,606,078,735.87
投资活动产生的现金流量净额514,465,812.65632,589,002.95470,473,743.64-1,437,862,014.12
筹资活动产生的现金流量:
筹资活动现金流入小计373,136,048.92283,499,548.9589,356,633.35738,862,372.18
筹资活动现金流出小计1,354,514,420.771,191,858,989.07628,311,014.691,019,025,287.25
筹资活动产生的现金流量净额-981,378,371.85-908,359,440.12-538,954,381.34-280,162,915.07
汇率变动对现金及现金等价物的影响-2,087,506.29202,617.314,003.552,990,123.33
现金及现金等价物净增加额146,483,747.88117,340,604.3994,416,109.55-988,873,435.05
期末现金及现金等价物余额433,628,680.58404,485,537.09381,561,042.25287,144,932.7
补充资料:
现金及现金等价物的净增加额-117,340,604.39--988,873,435.05
最新报告期:2025-11-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东方证券伍云飞0.911.071.252025-11-21
兴业证券孙媛媛0.921.051.252025-11-09
中银证券刘恩阳1.001.101.202025-09-08
西部证券李梦园0.931.091.232025-09-07
平安证券叶寅,韩盟盟0.961.101.282025-09-04
TOP↑